CW August 2003

category image Volume 12
Issue Number 8
August 2003
ISSN 10593802

FOLFOX and IROX Favored Over IFL in Metastatic Colorectal Cancer

In a large clinical trial, regimens containing oxaliplatin with either irinotecan or 5-FU/LV showed advantages over bolus 5-FU/LV in patients with metastatic colorectal cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

39th Annual Meeting of the American Association of Clinical Oncology.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW August 2003

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login